Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three injection sites licensed for Mounjaro are the abdomen, the front of the thigh, and the outer upper arm. Each works equally well for delivering tirzepatide — the medicine reaches the same destination regardless of which you choose. What matters most is rotating correctly between sites so no single patch of skin bears the full weekly load. Mounjaro is a prescription-only medicine; a prescriber assesses suitability before treatment begins, and your Patient Information Leaflet gives the authoritative guidance for your specific dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding about Mounjaro injection sites is that the abdomen is the "correct" one and the others are fallbacks. That is not accurate. The Mounjaro SmPC (the prescribing authority) lists the abdomen, thigh and upper arm as equivalent options. Tirzepatide is absorbed through subcutaneous tissue at all three sites; no head-to-head data shows a clinical difference in how the medicine performs depending on which you choose.
The reason people reach for this belief is probably familiarity: the abdomen is the site most often demonstrated in training, and it is the easiest to reach yourself. But ease of access matters practically. The outer upper arm is difficult to inject into without assistance if you are doing it alone, so most self-administering patients settle on the abdomen and thigh as their rotation pair. That is a reasonable practical choice, not a medical requirement.
If you want a fuller breakdown of how each site compares in everyday use, the site-by-site comparison for tirzepatide covers the practical differences in more detail. The short version: all three are valid; pick the two you can reach comfortably and rotate reliably between them.
The NHS medicines page for tirzepatide confirms the same three licensed sites and links to injection guidance worth reading before your first dose.
Good technique reduces the chance of a sore spot or a lumpy patch of skin developing over time. The principles are consistent across all three sites.
Wash your hands first. Clean the skin with an alcohol swab and let it dry fully, wet skin can sting. Pinch a generous fold of fatty tissue and insert the needle at roughly 90 degrees. On the abdomen, aim at least two inches away from the navel. On the thigh, use the front or outer surface of the upper leg, not the inner thigh. For the upper arm, the outer, slightly fleshy area is the target, ideally with someone else administering if you find the angle awkward alone.
Hold the pen firmly against the skin, press the button and keep pressure on until the injection is complete, the KwikPen's dose window confirms delivery. Do not rub the site afterwards; gentle pressure is fine. If you need alcohol swabs, they are available from the accessory range for your convenience.
Used needles go straight into a sharps bin. Leaving them exposed, even briefly, is a risk to anyone who handles your pen. A 1-litre sharps container sits neatly under a bathroom cabinet and takes the guesswork out of disposal.
Skin that receives an injection in exactly the same spot week after week develops lipodystrophy, a hardening or dimpling of subcutaneous fat. In that altered tissue, tirzepatide is absorbed unpredictably. Rotation is not optional comfort advice; it is the mechanism that keeps your treatment working reliably.
The practical system most people find easiest is to divide each site into a grid of small zones and move one zone along each week. Within the abdomen, for example, you might work around a clock face, leaving several centimetres between each point. When you have covered the abdomen fully, move to the thigh for a week or two, then back. The exact pattern matters less than the consistency.
Mounjaro is a once-weekly injection, so seven full days pass between doses. Keep a note in your phone or on the pen's packaging of where you injected last, after a few months the habit becomes automatic. Many people tie the injection to a fixed routine: Sunday morning before a shower, or the same evening they take other regular medication, keeping the pen in the fridge door next to something they open daily.
For more on the full injection process, including what to do if a dose is missed, the Mounjaro injection guide has step-by-step detail. Questions about rotating between sites or anything about technique are well worth raising with your prescriber at your next review. You can also explore the broader Mounjaro treatment overview for context on how tirzepatide works as part of a weight-management plan.
Mild redness, itching or a small lump at the injection site is common in the first few weeks and usually settles within a day or two. It reflects your skin adapting to the pen rather than a sign that anything has gone wrong. Rotating sites as described above reduces how often this happens.
A hard knot that persists, significant bruising, or any sign of infection (warmth, spreading redness, pus) should be assessed by a clinician. Do not inject into the affected area until it has healed. Persistent lumps in the same spot are a signal that rotation has been too narrow; widening the zone usually resolves it over the following weeks.
Allergic reactions to tirzepatide itself are rare but reported. Swelling of the face, lips or throat, difficulty breathing, or a widespread rash are urgent symptoms that need immediate medical attention, not a wait-and-see approach. The MHRA's Yellow Card scheme lets patients report side effects directly, and doing so contributes to ongoing safety monitoring for newer medicines like tirzepatide.
If you are thinking about whether Mounjaro might be right for you, the weight-loss treatment overview explains the options available, and our guide to finding the best place to inject Mounjaro walks through each location so you can make a confident choice before starting. If you are still weighing up your options, our separate guide on where it is best to inject Mounjaro offers a practical perspective alongside understanding where to inject Mounjaro as a good grounding before starting. When you are ready, speak to our prescribers through a free consultation, a GPhC-registered Independent Prescriber reviews every application personally, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.